ABBLO PHARMA ApS: Financial statements 2014
CVR: 34080534
Source: annual report 2014, Danish Business Authority
01/10/2013 – 30/09/2014
ABBLO PHARMA ApS (CVR 34080534) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -125,983 and a net result of DKK 2,000,538 compared with DKK -2,697,303 the year before. Equity in the 2014 report amounted to DKK -214,680.
- Gross Profit
- DKK -125,983
- Profit/Loss
- DKK 2,000,538
- Equity
- DKK -214,680
- Total Assets
- DKK 104,152
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -126 t. | 2 mio. | -215 t. | - |
| 2013 | - | -12 t. | -2.7 mio. | -2.2 mio. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of November 27, 2014, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of ABBLO PHARMA ApS.
As of October 7, 2014, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of ABBLO PHARMA ApS.
As of October 7, 2014, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ABBLO PHARMA ApS.
As of October 1, 2014, is registered as an owner of ABBLO PHARMA ApS with an ownership share of 100%.
ABBLO PHARMA ApS has published its annual report for 2013. Gross profit came to DKK -11,750, and the net result was DKK -2,697,303.
About ABBLO PHARMA ApS
ABBLO PHARMA ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2011. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nic Borch-Christensen and Mie Hjerrild Petersen. The board consists of Mie Hjerrild Petersen (chair) and Nic Borch-Christensen. The company is owned by ABBLO S.à.r.l. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. Equity in the 2025 report amounted to DKK -238,088.